arrow
A

Andrei C. Spósito

Department of Medicine
H指数:45
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A narrative review of what cohorts have taught us and how they have laid the foundation for much of our understanding of type 2 diabetes

关于队列研究带给我们的启示以及它们如何奠定我们对2型糖尿病理解基础的叙事性综述

2026-08-260
OAAI
Discrepancies in office blood pressure measurement protocols across international guidelines: Houston, we've got a problem.

国际指南中办公室血压测量协议的差异:休斯顿,我们有麻烦了。

2026-08-010
PRE
Intensive blood-pressure control for the prevention of major cardiovascular events in patients with type 2 diabetes: Rationale , design and baseline characteristics of the OPTIMAL-DIABETES randomized trial

强化血压控制以预防2型糖尿病患者主要心血管事件:OPTIMAL-DIABETES随机试验的原理、设计与基线特征

2026-08-010
PRE
Impact of in-hospital SARS-CoV-2 infection on mortality and outcomes in patients admitted for heart failure: a nationwide analysis in Brazil

巴西全国范围内住院期间SARS-CoV-2感染对因心力衰竭入院患者死亡率和预后的影响:一项全国性分析

2026-04-060
OAAI
LDL Subspecies and Lipidome Change by Evolocumab Add-on Therapy to Empagliflozin in Patients with Type 2 Diabetes: A Prespecified Secondary Analysis of a Randomized Clinical Trial

LDL亚种和脂质组学变化:在2型糖尿病患者的随机临床试验中,Evolocumab加用Empagliflozin治疗的预先设定的次要分析

2026-03-030
PRE
Screening for CKD in undiagnosed populations with diabetes and hypertension: lessons from the SEARCH study

对未诊断糖尿病和高血压人群进行慢性肾病筛查:SEARCH研究的经验教训

2026-01-010
PRE
Prasugrel or ticagrelor monotherapy vs dual antiplatelet treatment after percutaneous coronary intervention in acute coronary syndromes: a landmark analysis from the NEOMINDSET trial

急性冠脉综合征经皮冠状动脉介入治疗后普拉格雷或替格瑞洛单药治疗与双联抗血小板治疗的比较: 来自NEOMINDSET试验的里程碑分析

2025-12-190
OA
Metabolic outcomes and safety of GLP-1 receptor agonists in children and adolescents with obesity: A systematic review and meta-analysis

GLP-1受体激动剂在儿童和青少年肥胖患者中的代谢结局与安全性:一项系统评价和荟萃分析

2025-04-230
PRE
Discrepancies between office and home blood pressure targets in patients with hypertension according to the 2024 European Society of Cardiology Hypertension Guidelines

根据2024年欧洲心脏病学会高血压指南,高血压患者办公室与家庭血压目标之间的差异

2025-04-090
PRE